Free Trial

Colgate-Palmolive (NYSE:CL) Price Target Cut to $106.00 by Analysts at UBS Group

Colgate-Palmolive logo with Consumer Staples background

Colgate-Palmolive (NYSE:CL - Get Free Report) had its price objective lowered by research analysts at UBS Group from $109.00 to $106.00 in a research note issued on Thursday,Benzinga reports. The firm currently has a "buy" rating on the stock. UBS Group's target price suggests a potential upside of 21.45% from the company's previous close.

CL has been the subject of a number of other research reports. Barclays lifted their target price on Colgate-Palmolive from $86.00 to $87.00 and gave the stock an "equal weight" rating in a report on Tuesday. Wells Fargo & Company lifted their target price on Colgate-Palmolive from $83.00 to $88.00 and gave the company an "underweight" rating in a research report on Wednesday, April 2nd. JPMorgan Chase & Co. boosted their price target on Colgate-Palmolive from $95.00 to $103.00 and gave the stock an "overweight" rating in a report on Monday, April 28th. Citigroup upped their target price on Colgate-Palmolive from $103.00 to $108.00 and gave the company a "buy" rating in a report on Monday, April 28th. Finally, Piper Sandler reduced their target price on Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating on the stock in a report on Monday, March 31st. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and eight have given a buy rating to the company's stock. Based on data from MarketBeat, Colgate-Palmolive currently has a consensus rating of "Hold" and a consensus target price of $101.00.

Check Out Our Latest Stock Report on CL

Colgate-Palmolive Stock Down 0.4%

Shares of NYSE:CL traded down $0.38 during midday trading on Thursday, hitting $87.28. The stock had a trading volume of 3,788,095 shares, compared to its average volume of 4,860,882. Colgate-Palmolive has a 12 month low of $85.32 and a 12 month high of $109.30. The company has a quick ratio of 0.54, a current ratio of 0.85 and a debt-to-equity ratio of 8.96. The business's 50-day simple moving average is $90.40 and its 200-day simple moving average is $90.41. The company has a market cap of $70.73 billion, a P/E ratio of 24.66, a PEG ratio of 4.63 and a beta of 0.37.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its earnings results on Friday, April 25th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.86 by $0.05. Colgate-Palmolive had a net margin of 14.52% and a return on equity of 461.04%. The business had revenue of $4.91 billion during the quarter, compared to analysts' expectations of $4.92 billion. During the same period last year, the business earned $0.86 earnings per share. The firm's revenue was down 3.0% on a year-over-year basis. On average, sell-side analysts forecast that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive announced that its board has approved a share repurchase plan on Thursday, March 20th that authorizes the company to repurchase $5.00 billion in shares. This repurchase authorization authorizes the company to repurchase up to 6.8% of its shares through open market purchases. Shares repurchase plans are often a sign that the company's management believes its stock is undervalued.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. Westend Capital Management LLC grew its stake in shares of Colgate-Palmolive by 111.1% during the 1st quarter. Westend Capital Management LLC now owns 266 shares of the company's stock worth $25,000 after acquiring an additional 140 shares during the period. Cornerstone Planning Group LLC raised its holdings in shares of Colgate-Palmolive by 1,913.3% in the 1st quarter. Cornerstone Planning Group LLC now owns 302 shares of the company's stock valued at $28,000 after acquiring an additional 287 shares in the last quarter. Saudi Central Bank purchased a new stake in shares of Colgate-Palmolive in the 1st quarter valued at about $29,000. Vermillion Wealth Management Inc. purchased a new position in shares of Colgate-Palmolive during the 4th quarter valued at about $31,000. Finally, Bernard Wealth Management Corp. purchased a new position in shares of Colgate-Palmolive during the 4th quarter valued at about $33,000. Institutional investors own 80.41% of the company's stock.

About Colgate-Palmolive

(Get Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Strategy Beat the S&P—And Most Investors Ignore It
NVDA Greenlight: China Sales Spark 50% Rally Potential
Time to Cash Out? 5 Stocks to Drop Before Earnings

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines